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ABSTRACT
Objectives: Therapeutic hypothermia TH became broadly used in the management of the asphyxiated newborns. Although 
two cooling methods are used, so far the superiority of none of them has been established. The purpose of the study is to 
compare two cooling methods: selective head cooling (SHC) and whole body cooling (WBC)
Material and methods: We conducted a prospective observational study in newborns with HIE. The patients received one 
of methods: SHC or WBC. The eligibility criteria were similar to previous studies. Stability of cardio-respiratory parameters 
and short term outcomes were analyzed.
Results: 78 neonates with hypoxic-ischemic encephalopathy due to perinatal asphyxia were involved in this study. The SHC 
group consisted of 51 newborns, the WBC group consisted of 27 patients. Both study groups had similar baseline charac-
teristics and condition at birth. There were no significant differences in hospital course, neurological status and adverse 
effects associated with cooling procedure between groups. Analyzing the rate of thrombocytopenia and the number of 
transfusions of blood components no statistically significant differences were found between the groups. 
Conclusions: Results of our study indicate that two compared methods of TH despite varied target core temperature ranges 
do not differ significantly according to clinical course and risk of adverse events. Further observations are conducted and 
we look forward to the results of the long neurodevelopmental care.
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INTRODUCTION
Despite the advances in perinatal care, asphyxia of neo-
nates remains a serious condition leading to significant 
mortality and morbidity. According to WHO about 2.6 mil-
lion of deaths occur annually in the neonatal period. Peri-
natal asphyxia represents the third most common cause of 
neonatal death (23%) after preterm birth (28%) and severe 
infections (26%). It means that all over the world, almost 
600 000 newborns die every year and at least the same 
number develop severe consequences such as epilepsy, 
cerebral palsy and developmental delay due to acute peri-
natal sentinel events [1].
In the 90s of the last century, it was confirmed that the 
decline in brain temperature by 2°C to 5°C provided neuro-
protection [2–4]. Encouraging results of the first applications 
of therapeutic hypothermia in human neonates enabled 
to construct prospective randomized trials, initially with 
a control (not cooled) group of asphyxiated newborns. Re-
search results, since the pioneering studies [5, 6] through 
the multicenter trials, were convincing and led to immediate 
acceptance of medical devices for TH by the FDA [7–12]. 
The outcomes of RCT studies confirmed the lower mortality 
rates and improvement of neurodevelopmental outcomes 
in cooled neonates. Current guidelines for neonatal resus-
citation (since 2010) recommend the use of therapeutic 
hypothermia as a standard treatment in newborns with 
moderate or severe hypoxic-ischemic encephalopathy. 
The Olympic Cool-Cap providing selective head cooling 
with mild systemic hypothermia was the first method of cool-
ing approved by FDA in 2006 to be used in newborns with HIE.
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Subsequently, in 2010 Tecotherm Neo device — Inspira-
tion was introduced into the European market and at the 
same time (2010 and 2014) Arctic Sun TMS and Blanketrol AE; 
received the acceptance of the FDA. Apart from the Cool-Cap 
all the other devices mentioned above were dedicated to the 
second method of hypothermia: whole body cooling (WBC). 
The indications for hypothermia include: an acute hypoxia 
incident, Apgar score  ≤ 5 in 10 min, resuscitation for 10 min 
after birth or severe acidosis (pH < 7 or BE > 16 mmol/L) 
(in umbilical cord blood or in the first 60 min after birth), 
neurological symptoms of moderate or severe hypoxic-is-
chemic encephalopathy and pathological aEEG record-
ing [13]. Because of a very short therapeutic window after 
perinatal sentinel events the treatment with TH should be 
started in the first 6 hours of life and continued for 72 hours. 
The inclusion criteria also contain: the maturity above 
36 weeks of pregnancy and birth body weight > 1800g. Al-
though whole body cooling is now more popular and more 
commonly exploited, both methods are used and considered 
as appropriate and equivalent [14]. So far we have only a few 
studies comparing the two aforementioned methods of 
therapeutic hypothermia of newborns [15]. The superiority 
of either, SBC or WBC, has not been established. 
MATERIAL AND METHODS 
The prospective observational study was carried out in 
three centers. Two NICUs at level III perinatal centers and 
one Pediatric Intensive Care Unit participated in this study. 
The inclusion criteria were consistent with earlier randomized 
control trials: post menstrual age ≥ 36 weeks, Apgar ≤ 5 at 
10 minutes of life and umbilical cord blood pH < 7.1 and/or 
base excess (BE) ≥ 16 mmol/L, respiratory support until 10th 
minute of life. The exclusion criteria involved: major congenital 
malformations, life-threatening abnormalities and extremely 
poor prognosis (i.e. Apgar score 0 for longer than 10 minutes 
of life). Subsequently, all the considered infants were neuro-
logically examined according to Sarnat classification [16]. 
Newborns with clinical symptoms of moderate or severe 
HIE were further assessed with integrated EEG by means of 
infant electroencephalography Monitor Olympic CFM™ 6000, 
Natus Medical, USA. Moderately or severely abnormal aEEG 
traces were the entry criteria for therapeutic hypothermia. 
The selection of the cooling method, either WBC or SHC, 
depended on the cooling equipment available at the time 
in the care unit. The study protocol received the ethics ap-
proval of the bioethical board — PMMH — Research Institute 
Ethical Committee. Informed consent was obtained from all 
the legally designated representatives of the study neonates.
Therapeutic hypothermia protocol
Therapeutic hypothermia was initiated in the first 
6 hours of life and continued for 72 hours. The cooling pe-
riod was followed by a rewarming phase and the rewarming 
speed was set at 0.5°C per hour. Throughout the course of 
the cooling and rewarming process, vital signs (heart rate, 
arterial blood pressure, rectal temperature) and param-
eters of respiratory support (FiO2, MAP, level of respiratory 
support) were monitored and recorded every hour for the 
first 6 hours, then every three hours, and again every hour 
during the rewarming. A total of 36 measurements were 
taken. The vital signs were monitored using Philips IntelliVue 
MP70 Neonatal Monitors or Drager Infinity® Delta Monitors. 
The use of medicines like: vasopressors, anticonvul-
sants, steroids, volume expanders and inhaled nitric oxide 
were recorded. Parameters of coagulation were followed 
closely and the number of blood components transfusions 
(platelets, fresh frozen plasma, red blood cells) during the 
first 7 days of life were noted. Additionally, clinical data 
such as the number of seizure episodes, the incidence of 
IVH detected by cranial USG, the rate of PPHN confirmed 
by ECHO exam and feeding difficulties were analyzed. 
The assessment of the neurological status of the studied 
infants was carried out daily by trained personnel using the 
Thompson Encephalopathy Score [17] . 
Statistical analysis
In order to compare the percent accuracy between 
groups Chi-square or Fisher exact test were applied. One-way 
or two-way analysis of variance (ANOVA) was used for con-
tinuous data to investigate the differences between groups 
and changes observed over time. Fishers LSD (least sig-
nificant difference) post hoc comparison tests were used 
to identify any significant differences between mean val-
ues. Differences in the means of the ranks of the values 
between groups were analyzed with the Student’s t-test 
or Mann-Whitney U test. Statistical analysis was carried out 
using STATISTICA (StatSoft, Tulsa, OK, USA, version 6.0 PL). 
Statistical significance was assumed at p-value < 0.05.
RESULTS 
Seventy nine neonates were included in this study. 
The SHC group consisted of 51 newborns, the WBC group 
was composed of 27 patients. Table 1 shows demographic 
and clinical data of the study population. 
Groups had similar baseline characteristics and condi-
tion at birth. pH, BE values in umbilical cord blood, rectal 
temperature at admission and neurological assessment 
on the initiation of the cooling procedure were also simi-
lar between the groups. The majority of the analysed pa-
tients: 21 out of 27 (77.8%) of patients in WBC and 42 out 
of 51 (82.4 %) patients in the SHC were outborn so neona-
tal interfacility transport was used. Emergency C-section 
procedure rates did not differ between groups: 74.1% 
vs. 69.8% . Therapeutic hypothermia initiation time equaled 
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(mean, ± SD) 357 (± 122) and 317 (± 167) minutes in the WBC 
and SHC respectively (p-value 0.08).
The rectal temperature evidently varied between the 
groups: during the maintenance phase of hypothermia the 
average temperature in the WBC group was 33.5°C whereas 
in the SHC it amounted to 34.2°C (p-value 0.000). During 
the rewarming phase the differences gradually decreased 
reaching normothermia (Fig. 1).
In the WBC group the mean HR values equaled 
116.4 (SD ± 21.1) bpm, whereas in the SHC group 114.9 
(± 20.1) bpm; (p-value 0.58). A similar observation con-
cerned measurements of the mean arterial blood pressure 
which amounted to (mean ± SD) 51.1 (± 10.2) mmHg in the 
WBC group and to 49.4 (± 9.9) in the SHC group, however, 
a tendency to lower MABP was found in the SHC, (p-value 
0.099). Nonetheless, the difference between the groups was 
not statistically significant. Mean arterial pressure (MAP) in 
the 36 points of measurement in WBC and SHC groups are 
shown in Figure 2. Time 0 in these and subsequent figures 
designates the initiation of the cooling procedure.
Table 1. Demographic data and clinical characteristics of the study subjects
SHC 
51
WBC
27 p-value
Postmenstrual age [weeks];  
mean (± SD) 38.53 (± 1.7) 38.96 (± 1.9) 0.71
Female gender, number (%) 23 (43.4) 19 (70.3) 0.33
Birth body weight [g]; 
mean (±SD) 3213.6 (576.2) 3276.9 (625.7) 0.31
Cesarean delivery (%) 37 (69.8) 20 (74.1) 0.69
Apgar score:
@ 5 minutes; 
@10 minutes,
2.84 (± 1.71)
3.54 (± 1.70)
2.11 (± 1.89)
2.92 (± 1.87)
0.08
0.15
Umbilical blood pHa (± SD) 6.89 (0.151) 6.87 (0.184) 0.62
Outborns n (%) 42 (82.4) 21 (77.8) 0.63
Base excess (BE)* -19.92 (± 4.8) -19.78 (± 4.8) 0.92
Rectal temperature  
at admission [0C] 33.8 (± 1.81 ) 33.7 (± 1.63) 0.86
HIES (Thompson scale)   
at < 6 hrs of age
7th day of life 
10.36
1.87
11.06
2.66
0.49
0.75
Neonatal seizures prior to cooling (n; %) 26 (51.0) 7 (26.9) 0.04
TH initiation time 
[minutes of life] 317 (± 167) 357.0 (± 122) 0.08
The difference p-value of < 0.05 was considered statistically significant. 
athe worst values: umbilical cord blood or any blood sampling during the first hour after birth
Figure 1. Time sequence of changes in rectal temperature. The 
average rectal temperature during the maintenance and re-warming 
phase (WBC vs. SHC)
Figure 2. Mean arterial blood pressure during the whole TH 
procedure in the WBC and SHC groups [mmHg]
406
Ginekologia Polska 2019, vol. 90, no. 7
www. journals.viamedica.pl/ginekologia_polska
The analysis of the frequency of inotropes use did not 
reveal significant changes. Additionally, the mean number 
of days of inotropes administration calculated on the num-
ber of people in the group was not statistically significant 
(Tab. 2) .
When analyzing the course of hospitalization and the 
rate of complications, no differences were found. The res-
piratory support and oxygen supplementation time were 
not significantly different. However, the rate of neonates 
who required any respiratory support (MV or noninvasive 
support) between 36–80 hour of cooling was significantly 
higher in the WBC vs. SHC group, 83.6% vs. 72 % respectively; 
(p-value 0.047). During the whole therapeutic hypothermia 
procedure the fraction of inspired oxygen (p-value 0.99) and 
mean airway pressure (p-value 0.68) did not differ between 
the groups. 
The rate of PPHN decreased and the need for inhaled 
nitric oxide (INO) was reduced three-fold in the SHC group 
but the rate of its incidence was very low. The average 
platelets count in all controlled tests was similar in both 
groups. In the WBC group a statistically significant decrease 
in mean PLTs values was observed on the 2nd, 3rd and 4th 
days compared to baseline values in the first 24 hours. 
The reduction in the following days reached 38% of the ini-
tial value. A smaller reduction in average platelets values was 
observed in the SHC group, by only 21%. The incidence of 
Table 2. Hospital Course and Status at Discharge. Analysis of drug and blood components administration  in the first week of life
SHC 
51
WBC
27 p-value
Respiratory support No [%]
mean [days] (± SD)a 4.8 (± 3.6) 6.0 (± 6.6) 0.37
Noninvasive support [days]  
mean (± SD)aa 0.7 (± 1.3) 1.5 (± 3.6) 0.26
Oxygen therapy [days]  
mean (± SD) 5.6 (± 7.6) 4.5 (± 3.8) 0.47
Diagnosis of PPHN 
Administration of inhaled NO (INO)
6 (11.3)
2 (3.8)
5 (18.5)
4 (14.8)
0.38
0.08
Thrombocytopenia  
 100 000/microliter (μL) 
 Number; (%)
23
45.1
12
45.1 0.93
RBC transfusion   
(No; No of patients) 
No/patient
10/6
0.2
7/5
0.28 0.46
FFP transfusion  
(No; No of patients) 
No/all patients
20/12
0.39
24/13
0.89
0.36
PLT transfusion
No/patient
5/5
0.1
4/3
0.16 0.30
Catecholamine use:
none
1
≥ 2
Mean No of days/all patients 
18 (35.3%)
19 (31.4%)
17 (33.3%)
3.14
12 (44.4%)
1 (3.7%)
14 (51.8%)
4.04
0.08
0.19
Volume replacement therapy 
(No; No of patients) 
No/patient
5/5
0.2
13/9
0.25
0.20
Anticonvulsant administration  
(No of patients)
No of doses/all patients
40
141/2.8
24
80/2.9
0.94
Antibiotic therapy [days] mean (±SD) 14.5 (± 7.6) 13.1 (± 6.8) 0.43
Full enteral feeding 
Oral feedings (sucking)  
[days] mean (± SD)
14.5 (± 5.9)
16.7 (± 10.2)
14.7 (± 5.1)
14.3 (± 5.4)
0.92
0.37
Age at discharge/DOL mean (± SD) 27.26 (± 13.0) 21.91(± 11.3) 0.09
Death during hospital stay n (%) 3 (6.0) 2(8.3) 0.71
The p-value of < 0.05 was considered statistically significant 
aany type of mechanical ventilation (SIMV, PC, HFOV) 
aaany type of noninvasive respiratory support (noninvasive ventilation, nasal CPAP)
407
Ewa Matylda Gulczynska et al., Therapeutic hypothermia in asphyxiated newborns: selective head cooling vs. whole body cooling
www. journals.viamedica.pl/ginekologia_polska
thrombocytopenia  100 x 109/L found in each of the groups 
did not differ statistically significantly; (p-value 0.93). Also, 
the number of transfusions of different blood components 
(fresh frozen plasma, erythrocytes and platelets) did not differ 
significantly (Tab. 2).
Results of neonatal neurological status assessment per-
formed daily according to Thompson scale are presented in 
Figure 3. On the following days of the treatment, to the fifth 
day of study (after the hypothermia was completed), the 
score was comparable in both groups. The rate of neurologi-
cal status improvement expressed as a percentage decrease 
in Thompson scores was slightly better in SHC i.e. by 83.1% vs. 
74.3% in WBC group in comparison with initial values. 
DISCUSSION
Currently, therapeutic hypothermia is a standard treat-
ment of hypoxic-ischemic encephalopathy in neonates [18]. 
The SHC was the first method of therapeutic hypothermia 
utilized in the neonatal period. The only device is a system 
utilizing a special cooling cap to provide selective brain 
cooling while maintaining core temperature at safe levels 
through the use of a radiant warmer. The Cool-Cap works 
by maintaining a steady flow of cool water at a selected 
temperature through a plastic cap covering the infant’s 
head. The temperature is manually controlled. In this way 
the newborn’s brain is the coldest part of the body. The 
rectal temperature is maintained at the level of 34.0–35.0°C. 
When using the second method, whole body cooling 
(WHC), the temperature distribution is reversed. In such 
case, hypothermia is delivered in newborn infants using 
different types of mattresses or wraps around the body. 
The newborn’s brain cools backward through transfer of low 
temperature from the rest of the body. The temperature of 
the neonatal brain is probably higher compared to the tem-
perature in the rectum. Therefore, the target rectal tempera-
ture in the WBC method is slightly lower and maintained at 
the level of 33.5 ± 0.5°C. Nowadays, the whole body cooling 
method seems more popular and more often used. However, 
both methods are used as before and considered equivalent 
in terms of effectiveness. Because the target ranges of deep 
body temperature are different, many users pose a question 
of the side effects as well as the effectiveness of both meth-
ods. In the animal model (piglet), which has a much smaller 
head compared with the human newborn infant, using SHC 
it was possible to cool the basal ganglia to the temperature 
lower by 5°C than rectal temperature [18], however, in adults, 
a considerable temperature gradient between the surface 
of the head and deep brain structures, where the tempera-
ture is similar to rectal temperature (Trec), was observed. 
Therefore, deep brain temperature remains almost equal 
to core temperature even when extreme cold is applied 
to the surface of the head [19]. It seems possible that the 
temperature gradient between head surface and deep brain 
structure could be substantial and may have an influence on 
regional brain temperature. Theoretically, it is possible that 
fluctuations in Trec and, in consequence, brain temperature 
may adversely affect the neuroprotective effect of TH. There 
is evidence that brain temperature is an important factor 
in regulating BBB permeability, alterations in brain water 
homeostasis and subsequent structural abnormalities of 
brain cells [20]. So far, we have only a few studies comparing 
the two methods of therapeutic hypothermia employed in 
neonatal period [15].
As expected, in our studied group differences in Trec 
were observed. The mean Trec in WBC group was 33.5°C 
and was the same as noticed in TOBY trial [21]. In the SHC 
group mean Trec was only 34.2°C, which means that the 
differences were smaller than expected and amounted only 
to 0.66°C. It may express the tendency of the medical team 
to maintain a target temperature in the lower ranges in 
manually controlled devices. The stability of vital param-
eters: mean target Trec, ABP, and HR at hourly intervals were 
previously assessed by Hoque et al. [22]. They compared four 
groups of newborns: 1 group treated with SHC, and 3 groups 
receiving different variants of WBC. The authors did not find 
differences in mean ABP or mean HR between groups dur-
ing the maintenance phase of cooling. They noticed greater 
variation in Trec in the SHC group during rewarming phase. 
No other clinical outcomes were analyzed. 
Earlier studies have shown the effect of hypothermia on 
the frequency of inotropic agents used [7]. Meta-analysis 
of previous RCT (TH vs. control group) assessed cardio-
vascular effect and revealed increased risk of hypotension 
treated with inotropes in hypothermia group RR 1.17 (95% CI 
1.00, 1.38), RD 0.08 (0.00, 0.17) [23]. In our research, despite 
the obvious depth temperature measurements (Trec) dif-
Figure 3. The mode of respiratory support in the WBC and SHC 
groups during the whole TH procedure. Any type of applied 
mechanical ventilation (SIMV, PC, HFOV) and noninvasive respiratory 
support (noninvasive ventilation, nasal CPAP) were analyzed jointly
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ferences, we did not notice differences in the mean HR as 
well as mean ABP between groups. The rate and duration of 
inotropes administration were also similar. This observation 
is consistent with reports by other experts [24]. Although 
the SHC group was cooled using the standardized Cool Cap 
device, the low-tech method (cooling the baby’s environ-
ment using a room air conditioner) was used in the WBC 
group. No differences in the following clinical parameters: 
low blood pressure, bradycardia, thrombocytopenia, coagu-
lopathy, renal failure, necessity of respiratory support and 
discontinuation of mechanical ventilation or PPHN were 
identified during the cooling and rewarming procedure. 
Likewise, a non-randomized trial conducted at University 
of Michigan (WBC-28, SHC-31) confirmed that important 
components of multi-organ system dysfunction and hy-
potension treated with inotropes for > 24 h, commonly 
required in newborns with HIE, were similar for both meth-
ods of TH [25, 26]. 
The requirement for invasive mechanical ventilation, 
ability to perform extubation during the period of cooling 
and risk of PPHN were analyzed in two studies [25, 27]. 
No differences were found between groups in regard to the 
need of mechanical ventilation during the cooling or ability 
to be extubated during the cooling. In both analyses the rate 
of mechanical support while the cooling was being carried 
out was above 90%. In addition, the possibility of extubation 
and newborns breathing on their own during the cool-
ing procedure was confirmed (WBC 42.8% vs. SHC 37.9%). 
The highest values of peak inspiratory pressure (PIP), posi-
tive end-expiratory pressure (PEEP), FiO2 (fraction of inspired 
oxygen), and PaCO2 (partial pressure of carbon dioxide) were 
investigated during the cooling procedure. No differences 
were found in the above mentioned respiratory settings 
between WBC and SHC groups [28]. Our findings are con-
sistent with previous studies. Initially mechanical support 
was required by 92% of neonates in both groups, but at 
72 hours of cooling artificial ventilation was used only in 
65.2% SHC vs. 66.6% WBC. As was the case in the literature 
quoted earlier, we did not observe significant differences 
between analyzed groups. (Fig. 4, Tab. 2). In all three studies, 
the PPHN risk was higher in the WBC group but it did not 
reach statistical significance. 
Thrombocytopenia is one of the most frequently re-
ported side-effects of therapeutic hypothermia and its in-
cidence is significantly different and varies from 3–65%. 
Differences are probably related to definitions of throm-
bocytopenia and differences in timing of platelet count 
assessment [28]. Meta-analysis of four trials [5, 6, 19] showed 
statistically significantly increased thrombocytopaenia in 
the hypothermic groups (RR: 1.55, 95% CI: 1.14, 2.11, NNH: 
8, 95% CI: 5, 50) [29]. The next analysis (8 RCT) confirmed 
a risk of thrombocytopenia in the hypothermia group RR 
1.21 (95% CI 1.05–1.40) [23, 30]. The observed difference 
suggests an additional effect of hypothermia on platelet 
count in infants with perinatal asphyxia. A slight statistical 
increase in the risk of thrombocytopenia was detected in 
the group of infants treated with SHC [23]. In our study the 
frequency of thrombocytopenia was 32.7% (SHC) vs. 37% 
(WBC) and no statistical differences were observed. The 
aforementioned research conducted by Atici did not notice 
the differences in the risk of thrombocytopenia either [24]. 
Moreover, other researchers reported no differences in or-
gan failure parameters including haematological, coagulogi-
cal and cardiovascular ones [31].
The same team of researchers conducted a small ran-
domized study (17 in SHC vs. 12 in WBC group) and recorded 
the death rate at 41 vs. 33% and survivors without dis-
ability of 18 vs. 33% in the SHC and WBC respectively [32]. 
However, the differences did not reach the level of statisti-
cal significance, which may be ascribed to a limited study 
group. Finally, the same authors analyzed certain neural 
and inflammatory biomarkers. The serum interleukin (IL)-1β, 
IL-6, neuron-specific enolase (NSE), brain-specific creatine 
kinase (CK-BB), tumor necrosis factor-alpha (TNF-α), protein 
S100 levels, the urine S100B level and the urine lactate/creat-
inine (L/C) ratio were evaluated 6 and 72 hrs after birth. They 
did not observe significant differences between groups at 
assessed time points, neither did they find such differences 
when the changes between 6 and 72 h were determined 
in percentages [33]. 
Consistently with previous studies, also in our analysis 
no method has been proven superior. Although our research 
included the largest number of newborn infants investi-
gated so far, we did not observe additional clinical benefit 
of WBC technique. Despite the lack of clinical advantages, 
the simplicity of usage of WBC (due to servo-control) should 
be emphasized.
Figure 4. HIES — hypoxic ischemic encephalopathy score during the 
5th first days of life
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The limitation of this study was a lack of randomization 
and a smaller sample of WBC group. 
CONCLUSIONS
Both methods of therapeutic hypothermia are comparable. 
We did not find significant differences in short term outco-
mes and the risk of adverse effects between SHC vs. WBC in 
newborns with HIE. Our results require confirmation in the 
follow-up observation. The tendency to higher rate of PPHN 
in WBC group should be confirmed in subsequent studies
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